https://pipelinereview.com/Jazz-Pharmaceuticals-Announces-First-Patient-Enrolled-in-Phase-3-Clinical-Trial-Evaluating-Defibrotide-for-the-Potential-Prevention-of-VOD-in-High-Risk-Patients/